Irosustat
10mM in DMSO
- Product Code: 199015
CAS:
288628-05-7
| Molecular Weight: | 309.34 g./mol | Molecular Formula: | C₁₄H₁₅NO₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in the treatment of hormone-dependent cancers such as breast and prostate cancer. Acts as a dual inhibitor of steroid sulfatase and 17α-hydroxylase/17,20-lyase (CYP17), reducing the production of active estrogens and androgens. This helps suppress tumor growth that depends on these hormones. Investigated in clinical trials for postmenopausal women with advanced breast cancer and in men with castration-resistant prostate cancer. Shows potential in overcoming resistance to conventional hormone therapies by targeting multiple pathways in steroid synthesis.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿5,020.00 |
+
-
|
Irosustat
Used in the treatment of hormone-dependent cancers such as breast and prostate cancer. Acts as a dual inhibitor of steroid sulfatase and 17α-hydroxylase/17,20-lyase (CYP17), reducing the production of active estrogens and androgens. This helps suppress tumor growth that depends on these hormones. Investigated in clinical trials for postmenopausal women with advanced breast cancer and in men with castration-resistant prostate cancer. Shows potential in overcoming resistance to conventional hormone therapies by targeting multiple pathways in steroid synthesis.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :